Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter

American Journal of Pathology

Volumn 157, Issue 4, 2000, Pages 1137-1146

  Zhang, Qian ^a   Raghunath, Puthiyaveettil N ^a   Vonderheid, Eric ^b   Ødum, Niels ^c   Wasik, Mariusz A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; INTERLEUKIN 2 RECEPTOR; PHOSPHOTRANSFERASE; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CELL LINE; DEMETHYLATION; DEPHOSPHORYLATION; HUMAN; HUMAN CELL; METHYLATION; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; T CELL LYMPHOMA;

EID: 0033809993     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64629-9     Document Type: Article

References (63)

1. Isolation of a src homology 2-containing tyrosine phosphatase
2. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases
3. Protein tyrosine phosphatase containing SH2 domains: Characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p 12-p13
4. Characterization of hematopoietic intracellular protein tyrosine phosphatases: Description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences
5. Regulation of cell signaling by the protein tyrosine phosphatases, CD-45 and SHP-1
6. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals
7. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor: Loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells
8. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction
9. Protein tyrosine phosphatase-1C is rapidly phosphorylated in tyrosine in macrophages in response to colony stimulating factor-1
10. Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand
11. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
12. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
13. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1
14. Regulation of immune responses through inhibitory receptors
15. A novel phosphotyrosine motif with a critical amino acid at position-2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1
16. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors
17. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
18. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency
19. JAKS AND STATS: Biological implications
20. Interleukin-2 receptor γ chain mutations result in X-linked severe combined immunodeficiency in humans
21. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor γ chain
22. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain
23. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain
24. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2
25. Interaction of IL-1R beta and gamma c chains with Jak1 and Jak3: Implications for XSCID and XCID
26. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes
27. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission
28. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of STAT3 in human T lymphocytes
29. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
30. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development
31. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3
32. Defective lymphoid development in mice lacking Jak3
33. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I
34. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells
35. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome
36. Differences in phosphorylation of the IL-2R associated Jak/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia (ATLL)
37. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines
38. Phorbol ester stimulates the activity of a protein tyrosine phosphatase containing SH2 domains (PTP1C) in HL-60 leukemia cells by increasing gene expression
39. Phorbol ester-induced expression, phosphorylation, and translocation of protein-tyrosine-phosphatase 1C in HL-60 cells
40. Down-regulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes
41. Human protein tyrosine phosphatase 1C (PTPN6) gene structure: Alternate promoter usage and exon skipping generate multiple transcripts
42. CpG islands in chromatin organization and gene expression
43. The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera
44. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
45. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
46. Impaired Fas response and autoimmunity in Pten+/mice
47. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
48. Alterations in DNA methylation: A fundamental aspect of neoplasia
49. Cancer epigenetics comes of age
50. In vitro and in vivo effects of 5-aza-2'-deoxycytidine (Decitabine) on clonogenic cells from acute myeloid leukemia patients
51. Pilot study of 5-aza-2'-deoxycytidine (Decitabine) in the treatment of poor prognosis acute myelogenous leukemia patients: Preliminary results
52. A randomized phase II study on the effects of 5-aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: An EORTC Leukemia Cooperative Group phase II study (06893)
53. Preliminary results with 5-aza-2'-deoxycytidine(DAC)-containing chemotherapy in patients with relapsed or refractory acute leukemia. The EORTC Leukemia Cooperative Group
54. 5-Aza-2'-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromes
55. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes
56. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs
57. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA
58. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
59. A mammalian protein with specific demethylase activity for mCpG DNA
60. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors
61. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis
62. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins
63. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis